← Scroll for more →
Evommune, Inc. (EVMN)
Pharmaceutical Preparations
Latest Price
$6.73
TTM P/E
1.23
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
7.71
P/B Ratio
0.87
Institutional Ownership
96.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.29M | $70.0M | 14.58% | +358.7K | 2026-06-30 |
| RA Capital Management, L.P. | 3.49M | $46.0M | 9.63% | -- | 2026-06-30 |
| Price T Rowe Associates Inc | 1.94M | $25.0M | 5.35% | +821.9K | 2026-06-30 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.93M | $25.0M | 5.31% | -- | 2026-06-30 |
| JPMorgan Chase & Co | 1.55M | $23.0M | 4.28% | +244.2K | 2026-06-30 |
| Rtw Investments, LP | 1.50M | $19.0M | 4.14% | -- | 2026-06-30 |
| Nan Fung Group Holdings Ltd | 1.44M | $19.0M | 3.97% | -- | 2026-06-30 |
| Point72 Asset Management, L.P. | 1.44M | $19.0M | 3.96% | +1.40M | 2026-06-30 |
| Andera Partners | 1.39M | $18.0M | 3.84% | -505.4K | 2026-06-30 |
| Eventide Asset Management, LLC | 1.21M | $16.0M | 3.33% | -- | 2026-06-30 |